These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8695165)

  • 1. Serum beta 2-microglobulin and prognosis of patients with renal cell carcinoma.
    Rasmuson T; Grankvist K; Ljungberg B
    Acta Oncol; 1996; 35(4):479-82. PubMed ID: 8695165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum interleukin-6 in relation to acute-phase reactants and survival in patients with renal cell carcinoma.
    Ljungberg B; Grankvist K; Rasmuson T
    Eur J Cancer; 1997 Oct; 33(11):1794-8. PubMed ID: 9470835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of serum basic fibroblast growth factor on prognosis in human renal cell carcinoma.
    Rasmuson T; Grankvist K; Jacobsen J; Ljungberg B
    Eur J Cancer; 2001 Nov; 37(17):2199-203. PubMed ID: 11677107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic and prognostic role of preoperative circulating CA 15-3, CA 125, and beta-2 microglobulin in renal cell carcinoma.
    Lucarelli G; Ditonno P; Bettocchi C; Vavallo A; Rutigliano M; Galleggiante V; Larocca AM; Castellano G; Gesualdo L; Grandaliano G; Selvaggi FP; Battaglia M
    Dis Markers; 2014; 2014():689795. PubMed ID: 24692843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum immunosuppressive acidic protein doubling time as a prognostic factor for recurrent renal cell carcinoma after nephrectomy.
    Araki K; Igarashi T; Tobe T; Mizoguchi K; Suzuki H; Furuya Y; Ichikawa T; Nakatsu HO; Ito H
    Urology; 2006 Dec; 68(6):1178-82. PubMed ID: 17141843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of five glycoprotein tumour markers (CEA, CA-50, CA-19-9, CA-125, CA-15-3) for the prognosis of renal-cell carcinoma.
    Grankvist K; Ljungberg B; Rasmuson T
    Int J Cancer; 1997 Apr; 74(2):233-6. PubMed ID: 9133462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumour vascular endothelial growth factor (VEGF) mRNA in relation to serum VEGF protein levels and tumour progression in human renal cell carcinoma.
    Ljungberg B; Jacobsen J; Häggström-Rudolfssson S; Rasmuson T; Lindh G; Grankvist K
    Urol Res; 2003 Oct; 31(5):335-40. PubMed ID: 14574539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble ectodomain of c-erbB-2 oncoprotein in relation to tumour stage and grade in human renal cell carcinoma.
    Rasmuson T; Grankvist K; Ljungberg B
    Br J Cancer; 1997; 75(11):1674-7. PubMed ID: 9184185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum beta-2-microglobulin levels in urological cancer.
    Bunning RA; Haworth SL; Cooper EH
    J Urol; 1979 May; 121(5):624-5. PubMed ID: 86616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parathyroid hormone-related protein and serum calcium in patients with renal cell carcinoma.
    Papworth K; Grankvist K; Ljungberg B; Rasmuson T
    Tumour Biol; 2005; 26(4):201-6. PubMed ID: 16006777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Basic Parameters of Blood Count, Serum Sodium, and Creatinine as Prognostic Factors for Renal Cell Carcinoma at Five-Year Follow-Up.
    Życzkowski M; Prokopowicz G; Taborowski P; Nowakowski K; Rajwa P; Stelmach P; Paradysz A
    Med Sci Monit; 2018 Jun; 24():3895-3902. PubMed ID: 29885161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased serum cortisol levels are associated with high tumour grade in patients with renal cell carcinoma.
    Rasmuson T; Ljungberg B; Grankvist K; Jacobsen J; Olsson T
    Acta Oncol; 2001; 40(1):83-7. PubMed ID: 11321667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum beta 2-microglobulin: a real improvement in the management of multiple myeloma?
    van Dobbenburgh OA; Rodenhuis S; Ockhuizen T; Weltevreden E; Houwen B; Fidler V; Meijer S; Marrink J
    Br J Haematol; 1985 Dec; 61(4):611-20. PubMed ID: 3910076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of elevated serum beta 2-microglobulin levels in adult acute lymphocytic leukemia.
    Kantarjian HM; Smith T; Estey E; Polyzos A; O'Brien S; Pierce S; Beran M; Feldman E; Keating MJ
    Am J Med; 1992 Dec; 93(6):599-604. PubMed ID: 1466355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased preoperative serum C-reactive protein level predicts a poor prognosis in patients with localized renal cell carcinoma.
    Komai Y; Saito K; Sakai K; Morimoto S
    BJU Int; 2007 Jan; 99(1):77-80. PubMed ID: 16956357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of serum C-reactive protein (CRP) as an independent prognostic factor for disease-free survival in patients with localised renal cell carcinoma (RCC).
    de Martino M; Klatte T; Seemann C; Waldert M; Haitel A; Schatzl G; Remzi M; Weibl P
    BJU Int; 2013 Jun; 111(8):E348-53. PubMed ID: 23495750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are angiogenic factors, cytokines, and soluble adhesion molecules prognostic factors in patients with renal cell carcinoma?
    Dosquet C; Coudert MC; Lepage E; Cabane J; Richard F
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2451-8. PubMed ID: 9815646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative high levels of serum vascular endothelial growth factor are a prognostic marker for poor outcome after surgical treatment of renal cell carcinoma.
    Guðbrandsdottir G; Hjelle KM; Frugård J; Bostad L; Aarstad HJ; Beisland C
    Scand J Urol; 2015; 49(5):388-94. PubMed ID: 25773545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of serum-soluble CD95 (Fas/APO-1) on prognosis in renal cell cancer patients.
    Kimura M; Tomita Y; Imai T; Saito T; Katagiri A; Tanikawa T; Takeda M; Takahashi K
    Br J Cancer; 1999 Jul; 80(10):1648-51. PubMed ID: 10408413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteopontin but not parathyroid hormone-related protein predicts prognosis in human renal cell carcinoma.
    Papworth K; Bergh A; Grankvist K; Ljungberg B; Sandlund J; Rasmuson T
    Acta Oncol; 2013 Jan; 52(1):159-65. PubMed ID: 22731830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.